Individual psychological responses to chronic pain may determine who benefits most from innovative fibromyalgia treatments, potentially revolutionizing how clinicians select and customize interventions for this complex condition affecting millions worldwide. This finding challenges the one-size-fits-all approach currently dominating fibromyalgia care.
A secondary analysis of 65 women with fibromyalgia examined whether specific psychological and behavioral factors influence treatment outcomes when patients receive multicomponent therapy combining graded motor imagery with therapeutic neuroscience education, compared to standard pharmacotherapy and physician education. The research identified pain catastrophizing and fear of movement (kinesiophobia) as key moderating variables that predicted treatment response, alongside baseline characteristics including physical activity levels, age, and nutritional status.
This represents a significant advancement in precision medicine for fibromyalgia, a condition notorious for inconsistent treatment responses and patient frustration. The identification of psychological moderators suggests clinicians could potentially screen patients before treatment selection, directing those with high catastrophizing or kinesiophobia toward specialized multicomponent interventions while reserving standard approaches for others. The study's focus on graded motor imagery—a neuroplasticity-based technique that retrains pain processing pathways—aligns with emerging understanding of fibromyalgia as a central sensitization disorder rather than purely peripheral tissue damage. However, the relatively small sample size and single-center design limit generalizability, and the secondary analysis nature means these moderating effects require confirmation in larger, purpose-designed trials before clinical implementation.